Akhtar Nida, Pathak Kamla
Department of Pharmaceutics, Rajiv Academy for Pharmacy, N.H. #2, Delhi-Mathura Road, P.O. Chhatikara, Mathura, 281001, Uttar Pradesh, India.
Department of Pharmaceutics, Pharmacy College Saifai, Uttar Pradesh University of Medical Sciences, Saifai, Etawah- 206130, Uttar Pradesh, India.
Recent Pat Drug Deliv Formul. 2017;11(1):5-18. doi: 10.2174/1872211311666170313124335.
BACKGROUND: Probiotics are the live microbes that exert beneficial effects on the health of the host cell, creating novel nanoformulations via probiotic bacteria, thus gaining tremendous momentum recently. The probiotic bacteria are being employed in synthesizing or more specifically biosynthesizing several nanoparticles like metallic as well as non-metallic nanoparticles. Biosynthesis of metallic nanoparticles is currently the focus of research nowadays due to several applications. Research inputs have led to the exploration of probiotic bacteria in biosynthesizing novel metallic nanoparticles. OBJECTIVE: The present review explores various research and patent reports on metallic nanoparticles biosynthesized using probiotic bacteria. METHOD: Through the sites, www.freepatentsonline.com and www.uspto.gov/patft, patents have been retrieved including US patents, EP and WIPO patents. RESULTS: Various reports and patents have revealed that probiotic bacteria can effectively produce metallic nanoparticles. These nanoparticles have found applications in cosmetics, pharmaceutics, medicine and biotechnology. Areas of future research can include the exploration of formulation aspects of metallic nanoparticles of iron, zinc, tellurium and synthesis of these particles using yeast, fungi, plant extracts and several biomaterials. CONCLUSION: Use of probiotic bacteria in synthesizing metallic nanoparticles is an effective biosynthetic approach. However, the technique needs wider exploration for newer metallic/nonmetallic/metalloid NPs for therapeutic applications.
背景:益生菌是对宿主细胞健康产生有益影响的活微生物,通过益生菌制造新型纳米制剂,近年来发展势头迅猛。益生菌正被用于合成,或者更具体地说是生物合成多种纳米颗粒,如金属和非金属纳米颗粒。由于多种应用,金属纳米颗粒的生物合成目前是研究的重点。研究投入促使人们探索利用益生菌生物合成新型金属纳米颗粒。 目的:本综述探讨了利用益生菌生物合成金属纳米颗粒的各种研究和专利报告。 方法:通过www.freepatentsonline.com和www.uspto.gov/patft网站检索专利,包括美国专利、欧洲专利和世界知识产权组织专利。 结果:各种报告和专利表明,益生菌能有效生产金属纳米颗粒。这些纳米颗粒已在化妆品、制药、医学和生物技术领域得到应用。未来的研究领域可包括探索铁、锌、碲金属纳米颗粒的制剂方面,以及利用酵母、真菌、植物提取物和几种生物材料合成这些颗粒。 结论:利用益生菌合成金属纳米颗粒是一种有效的生物合成方法。然而,该技术需要更广泛地探索用于治疗应用的新型金属/非金属/类金属纳米颗粒。
Recent Pat Drug Deliv Formul. 2017
Recent Pat Drug Deliv Formul. 2018
Recent Pat Nanotechnol. 2024
Sci Total Environ. 2022-9-10
Curr Microbiol. 2022-4-9
Crit Rev Microbiol. 2016-11
Probiotics Antimicrob Proteins. 2025-8-8